Microbial Biotechnology Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180001, India; Academy of Scientific and Innovative Research (AcSIR), Jammu Campus, Jammu 180001, India; Groupe Mer, Molécules, Santé-EA 2160, Faculté des Sciences pharmaceutiques et biologiques, Université de Nantes, 9 rue Bias, BP 53508, F-44035 Nantes Cedex 01, France.
Natural Product Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180001, India; Academy of Scientific and Innovative Research (AcSIR), Jammu Campus, Jammu 180001, India.
Biotechnol Adv. 2020 May-Jun;40:107521. doi: 10.1016/j.biotechadv.2020.107521. Epub 2020 Jan 15.
Natural products (NPs) are considered as a cornerstone for the generation of bioactive leads in drug discovery programs. However, one of the major limitations of NP drug discovery program is "rediscovery" of known compounds, thereby hindering the rate of drug discovery efficiency. Therefore, in recent years, to overcome these limitations, a great deal of attention has been drawn towards understanding the role of microorganisms' co-culture in inducing novel chemical entities. Such induction could be related to activation of genes which might be silent or expressed at very low levels (below detection limit) in pure-strain cultures under normal laboratory conditions. In this review, chemical diversity of compounds isolated from microbial co-cultures, is discussed. For this purpose, chemodiversity has been represented as a chemical-structure network based on the "Tanimoto Structural Similarity Index". This highlights the huge structural diversity induced by microbial co-culture. In addition, the current trends in microbial co-culture research are highlighted. Finally, the current challenges (1 - induction monitoring, 2 - reproducibility, 3 - growth time effect and 4 - up-scaling for isolation purposes) are discussed. The information in this review will support researchers to design microbial co-culture strategies for future research efforts. In addition, guidelines for co-culture induction reporting are also provided to strengthen future reporting in this NP field.
天然产物 (NPs) 被认为是药物发现计划中产生生物活性先导化合物的基石。然而,NP 药物发现计划的主要限制之一是“重新发现”已知化合物,从而阻碍了药物发现效率的提高。因此,近年来,为了克服这些限制,人们非常关注理解微生物共培养在诱导新型化学实体方面的作用。这种诱导可能与基因的激活有关,而这些基因在纯培养物中在正常实验室条件下可能处于沉默或表达水平非常低(低于检测限)。在这篇综述中,讨论了从微生物共培养物中分离得到的化合物的化学多样性。为此,基于“Tanimoto 结构相似性指数”,将化学多样性表示为化学结构网络。这突出了微生物共培养所诱导的巨大结构多样性。此外,还强调了微生物共培养研究的当前趋势。最后,讨论了当前的挑战(1 - 诱导监测、2 - 可重复性、3 - 生长时间效应和 4 - 分离的放大)。本综述中的信息将支持研究人员为未来的研究工作设计微生物共培养策略。此外,还提供了共培养诱导报告的指南,以加强该 NP 领域的未来报告。